Bioharvest Sciences (BHST) Total Current Liabilities (2023 - 2025)

Bioharvest Sciences' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $7.7 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 46.11% year-over-year to $7.7 million in Q4 2025; TTM through Dec 2025 was $7.7 million, a 46.11% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, down 46.11% from the prior year.
• Total Current Liabilities eased to $7.7 million in Q4 2025 per BHST's latest filing, from $13.2 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $26.5 million in Q4 2023 and bottomed at $7.7 million in Q4 2025.
• The 3-year median for Total Current Liabilities is $14.3 million (2024), against an average of $14.5 million.
• Across the five-year window, Total Current Liabilities plunged 46.13% in 2024 and soared 91.37% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $26.5 million in 2023, then plunged by 46.13% to $14.3 million in 2024, then plunged by 46.11% to $7.7 million in 2025.
• Per Business Quant, the three latest BHST Total Current Liabilities figures stand at $7.7 million (Q4 2025), $13.2 million (Q3 2025), and $17.1 million (Q2 2025).